论文部分内容阅读
来自于法国的一项最新研究结果显示,4天一个疗程的奈韦拉平(naviralapine,NP)与两种核苷类似物联用1个月被视作为一种安全的HIV暴露后(PEP)的预防疗法。
A new study from France shows that a 4-day course of nevirapine (NP) combined with two nucleoside analogues for 1 month is considered as a safe prophylaxis for post-HIV exposure (PEP) .